A RANDOMIZED, NON-INFERIORITY STUDY COMPARING EFFICACY AND SAFETY OF A SINGLE DOSE OF PEGFILGRASTIM VERSUS DAILY FILGRASTIM IN PEDIATRIC PATIENTS AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANT.
Account has been disabled due to a violation of Terms of Service. Contact Moderators
Account has been disabled due to a violation of Terms of Service. Contact Moderators